Rebecca Ross

Cooley advised Community, a short message service (SMS) customer engagement platform that connects businesses, brands, political and public figures, creators, musicians, celebrities and more, on its $25 million Series B financing. Partner Dave Young led the Cooley team.

Cooley advised the underwriters of Viking Therapeutics – a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders – on its $632.5 million public offering of common stock.

Cooley advised Rasa, a leading generative conversational artificial intelligence platform, on its $30 million Series C financing.

Cooley advised Delphix, a vendor of test data management software, on its acquisition by Perforce, a provider of solutions to enterprise teams requiring productivity, visibility and scale along the development life cycle.

Cooley advised Alto Neuroscience, a company redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and highly effective medicines and helping patients get better faster, on its $147.9 million initial public offering.